- Home
- DTCK vs PMCB Comparison
DTCK vs PMCB Comparison
Compare DTCK & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- PMCB
- Stock Information
- Founded
- DTCK 1999
- PMCB 1996
- Country
- DTCK Singapore
- PMCB United States
- Employees
- DTCK N/A
- PMCB N/A
- Industry
- DTCK Farming/Seeds/Milling
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTCK Industrials
- PMCB Health Care
- Exchange
- DTCK Nasdaq
- PMCB Nasdaq
- Market Cap
- DTCK 12.0M
- PMCB 11.4M
- IPO Year
- DTCK 2023
- PMCB N/A
- Fundamental
- Price
- DTCK $0.62
- PMCB $1.24
- Analyst Decision
- DTCK
- PMCB
- Analyst Count
- DTCK 0
- PMCB 0
- Target Price
- DTCK N/A
- PMCB N/A
- AVG Volume (30 Days)
- DTCK 42.0K
- PMCB 17.0K
- Earning Date
- DTCK 11-13-2024
- PMCB 03-17-2025
- Dividend Yield
- DTCK N/A
- PMCB N/A
- EPS Growth
- DTCK N/A
- PMCB N/A
- EPS
- DTCK 0.02
- PMCB 1.29
- Revenue
- DTCK $159,836,000.00
- PMCB N/A
- Revenue This Year
- DTCK N/A
- PMCB N/A
- Revenue Next Year
- DTCK N/A
- PMCB N/A
- P/E Ratio
- DTCK $28.63
- PMCB $0.88
- Revenue Growth
- DTCK N/A
- PMCB N/A
- 52 Week Low
- DTCK $0.40
- PMCB $1.03
- 52 Week High
- DTCK $1.73
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- DTCK 44.73
- PMCB 45.37
- Support Level
- DTCK $0.48
- PMCB $1.11
- Resistance Level
- DTCK $0.62
- PMCB $1.27
- Average True Range (ATR)
- DTCK 0.08
- PMCB 0.11
- MACD
- DTCK 0.02
- PMCB 0.01
- Stochastic Oscillator
- DTCK 54.55
- PMCB 71.19
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.